Javier García Marín
orcid.org/0000-0002-5883-4783
Publons: R-6014-2016
- 2023-Present: Assistant Professor, Universidad de Alcalá.
- 2022-2023:’Margarita Salas’ Postdoctoral Research Fellow, University of Bath (United Kingdom) (Prof. Carmen Domene).
- 2020-2022: Postdoc Sonsoles Martín Santamaría group, Centro de Investigaciones Biológicas Margarita Salas (CIB-CSIC). Thesis defense, 23.09.2020.
- 2018: Predoctoral stay at University of Bristol, Center for Computational Chemistry, (United Kingdom) (Prof. Adrian. J. Mulholland).
- 2017-2020 FPU grant MINECO.
- 2016-2017: FPI grant Universidad de Alcalá.
- 2015: Master Drug Discovery, Universidad Complutense de Madrid.
- 2014: Graduated (Pharmacy) at the Universidad Complutense de Madrid.
- 2013: CNIO Summer Training Program Fellow at Spanish National Cancer Research Center (CNIO) / Experimental Therapeutics Programme, Medicinal Chemistry Section (Dr. Joaquín Pastor / Sonia Martínez).
Publications in the group
Insight into the mechanism of molecular recognition between human Integrin-Linked Kinase and Cpd22 and its implication at atomic level.
Pyridazino-pyrrolo-quinoxalinium salts as highly potent and selective leishmanicidal agents targeting trypanothione reductase.
A Computer-Driven Scaffold-Hopping Approach Generating New PTP1B Inhibitors from the Pyrrolo%1,2-a%quinoxaline Core.
Pyrrolo%1,2-a%quinoxal-5-inium salts and 4,5-dihydropyrrolo%1,2-a%quinoxalines: Synthesis, activity and computational docking for protein tyrosine phosphatase 1B.
Tripeptides as Integrin-Linked Kinase Modulating Agents Based on a Protein-Protein Interaction with α-Parvin.
Pyrrolo%@5B1,2-a%@5Dquinoxalines: Insulin Mimetics that Exhibit Potent and Selective Inhibition against Protein Tyrosine Phosphatase 1B.